Losing weight can be a challenge at any stage of life, but some ages seem to make it even trickier. Factors like metabolism, ...
Drugmaker Eli Lilly plans to invest $3 billion to expand a manufacturing facility in the Kenosha County, Wis., to meet growing demand for its diabetes and weight-loss medicines.
Prediabetes affects almost 100 million Americans, but many don't know it. A patient shares their wake-up call, while a doctor ...
New research associated dark chocolate with a lower risk for type 2 diabetes. But experts say that the observational findings ...
There’s no single GLP-1 diet plan you need to follow. If you’re taking — or thinking about taking — a GLP-1 medication like ...
Teladoc Health, one of the largest telehealth providers in the US, offers diabetes management to its members with expert ...
Wegovy, Ozempic, Mounjaro and retatrutide – the ‘miracle’ drugs are booming. We assess whether they’re safe and how they ...
Postpartum weight loss can feel impossible at times, especially if the weight isn’t coming off as quickly as you expected.
Eli Lilly's weight-loss jab Mounjaro has been cleared for rollout by the NHS in England, with around 3.4 million people ...
Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Results from a ...
Mounjaro will be made available on the NHS but the rollout will be phased - only those with the highest need will get the ...